FindTrial
Sign In

A clinical trial of Intramyometrial injection of Carbetocin versus Oxytocin to prevent Postdelivery bleeding during caesarean section.

A Novel Prospective study of Intramyometrial injection of carbetocin versus oxytocin for prevention of Postpartum haemorrhage during caesarean section. - MYOCARB

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036792
Enrollment
100
Registered
2021-09-23
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O722- Delayed and secondary postpartum hemorrhage

Interventions

Intervention1: Carbetocin: To study the efficacy of Intramyometrial injection of heat stable carbetocin before separation of placenta for prevention of Postpartum haemorrhage during caesarean section

Sponsors

BLDEDU Shri BM Patil Medical College Hospital and Research Center Vijayapura
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women �18 years not in active labour undergoing caesarean section

Exclusion criteria

Exclusion criteria: Active labour with cervical dilation ââ?°Â¥6cm ïâ??· Women with known or suspected antenatal hypertensive disorders of pregnancy ïâ??· Intrapartum hypertension (defined as a single systolic blood pressureââ?°Â¥ 160 mmHg, or two consecutive blood pressures of ââ?°Â¥ 140 mmHg systolic or ââ?°Â¥ 90 mmHg diastolic taken 30 min apart), ïâ??· Antepartum haemorrhage of ââ?°Â¥ 50 ml, ïâ??· Confirmed maternal coagulation disorder ïâ??· Intrauterine fetal death in the current pregnancy ïâ??· Women who would decline blood and blood products, ïâ??· Women with peripheral vascular, cardiac or hepatic disease, ïâ??· Women with epilepsy, 1 ïâ??· Women with an allergy or sensitivity to any of the ingredients in any of the study drugs,

Design outcomes

Primary

MeasureTime frame
to compare the difference in the pre-operative hemoglobin and post-operative hemoglobin levels in both the groupsTimepoint: 0 min,5min,10min,60min—

Secondary

MeasureTime frame
To assess the uterine tone, advesrse effects of the drug and need of additional uterotonicsTimepoint: 1 min, 5min 10 min, 60 min—

Countries

India

Contacts

Public ContactDr Rajasri G Yaliwal

BLDE(DU) Shri BM Patil Medical College, Hospital and Research Center

ryaliwal@bldedu.ac.in9845152240

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026